Clinicians can now order tests and access discrete biomarkers within the patient's electronic health record, rather than rely on PDF-based genetic testing results.
Subscribe to:
Post Comments (Atom)
< + > Implicity Secures $40M Growth Equity Funding to Scale its AI-Driven Cardiac Monitoring Platform Globally
The Round is Led by Growth Fund IRIS Alongside Five Arrows Funding Will Fuel Implicity’s Next Phase of Growth in the US Through Local Comm...
-
As I’m sure you know, times are tough. Wages have largely remained the same while prices have risen across the board – and healthcare is no ...
-
Solution Erases Long Phone Holds for Patients, Supports Overwhelmed Medical Front Desk Workers, and Improves Patient Access to Physicians A...
-
Announcement written by Zack Kanter, Founder and CEO at Stedi In February of last year, I gathered our engineering team in a war room. Chan...
No comments:
Post a Comment